A detailed history of Brinker Capital Investments, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 3,510 shares of UTHR stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,510
Previous 88,604 96.04%
Holding current value
$1.48 Million
Previous $25.5 Million 96.04%
% of portfolio
0.01%
Previous 0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 27, 2025

SELL
$276.47 - $328.4 $23.5 Million - $27.9 Million
-85,094 Reduced 96.04%
3,510 $1.01 Million
Q2 2025

Aug 14, 2025

BUY
$276.47 - $328.4 $23.4 Million - $27.8 Million
84,506 Added 2062.13%
88,604 $25.5 Million
Q1 2025

Jul 31, 2025

BUY
$304.42 - $380.78 $23,440 - $29,320
77 Added 1.91%
4,098 $1.26 Million
Q4 2024

Jul 31, 2025

BUY
$348.66 - $410.0 $256,265 - $301,350
735 Added 22.37%
4,021 $1.42 Million
Q3 2024

Jul 31, 2025

BUY
$311.04 - $363.55 $383,512 - $448,257
1,233 Added 60.06%
3,286 $1.18 Million
Q2 2024

Jul 31, 2025

BUY
$228.26 - $319.04 $33,554 - $46,898
147 Added 7.71%
2,053 $653,000
Q1 2024

Jul 31, 2025

SELL
$210.76 - $249.51 $24,869 - $29,442
-118 Reduced 5.83%
1,906 $437,000
Q4 2023

Jul 31, 2025

SELL
$214.88 - $256.94 $35,884 - $42,908
-167 Reduced 7.62%
2,024 $445,000
Q3 2023

Jul 31, 2025

BUY
$211.82 - $248.24 $108,240 - $126,850
511 Added 30.42%
2,191 $494,000
Q2 2023

Jul 31, 2025

BUY
$205.19 - $232.99 $30,368 - $34,482
148 Added 9.66%
1,680 $370,000
Q1 2023

Jul 31, 2025

BUY
$212.99 - $276.17 $326,300 - $423,092
1,532 New
1,532 $343,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $19.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.